Palogic Value Management, L.P. Merck & Co., Inc. Transaction History
Palogic Value Management, L.P.
- $236 Billion
- Q2 2024
A detailed history of Palogic Value Management, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Palogic Value Management, L.P. holds 4,250 shares of MRK stock, worth $432,947. This represents 0.22% of its overall portfolio holdings.
Number of Shares
4,250
Previous 4,250
-0.0%
Holding current value
$432,947
Previous $561 Million
6.18%
% of portfolio
0.22%
Previous 0.24%
Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,805Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.38 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.81 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $258B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...